ABBV
64
2
ADSK
45
2
FLR
23
-2
MAS
54
-4
IVZ
42
2
AEP
77
3
CCL
64
-3
KO
55
-4
FRT
58
7
NWL
52
4
SHW
56
-2
MS
58
3
MDT
60
-4
GILD
62
3
COF
47
2
LB
59
24
NWS
28
2
AMG
79
2
NDAQ
38
3
ETR
74
6
ABBV
64
2
ADSK
45
2
FLR
23
-2
MAS
54
-4
IVZ
42
2
AEP
77
3
CCL
64
-3
KO
55
-4
FRT
58
7
NWL
52
4
SHW
56
-2
MS
58
3
MDT
60
-4
GILD
62
3
COF
47
2
LB
59
24
NWS
28
2
AMG
79
2
NDAQ
38
3
ETR
74
6
Financhill
Back

Roivant Sciences Ltd. 10K Form

Buy
55

ROIV
Roivant Sciences Ltd.

Last Price:
$27.05
Seasonality Move:
-7.14%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ROIV News And Ratings

See the #1 stock for the next 7 days that we like better than ROIV

ROIV Financial Statistics

Sales & Book Value

Annual Sales: $29.1M
Cash Flow: $-191.5M
Price / Cash Flow: 0
Annual Sales: $6.02
Price / Book: 4.43

Profitability

EPS (TTM): -1.16850
Net Income (TTM): $-1B
Gross Margin: $20.8M
Return on Equity: -19.87%
Return on Assets: -18.95%

Roivant Sciences Ltd. Earnings Forecast

Key Roivant Sciences Ltd. Financial Ratios

  • The Gross Profit Margin over the past 7 years for ROIV is 71.63%.
  • The Selling, General & Administrative Expenses for ROIV have been equal to 2,035.62% of Gross Profit Margin.
  • The Research & Development expenses have been 1,894.51% of Revenue.
  • The Net Earning history of ROIV is -2,511.84% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 3 years.

Roivant Sciences Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ROIV
Website: roivant.com

Debt

Debt-to-Equity Ratio: 0.03
Current Ratio: 30.66
Quick Ratio: 29.83

Price-to-Earnings

Trailing P/E Ratio: 2.16
Forward P/E Ratio: 0

ROIV Technical Analysis vs Fundamental Analysis

Buy
55
Roivant Sciences Ltd. (ROIV) is a Buy

Is Roivant Sciences Ltd. a Buy or a Sell?